Human genome-guided identification of memory-modulating drugs

Papassotiropoulos A, Gerhards C, Heck A, Ackermann S, Aerni A, Schicktanz N, Auschra B, Demougin P, Mumme E, Elbert T, Ertl V, et al. (2013)
Proceedings of the National Academy of Sciences of the United States of America 110(46): E4369-E4374.

Journal Article | Published | English

No fulltext has been uploaded

Author
; ; ; ; ; ; ; ; ; ; ;
All
Abstract
In the last decade there has been an exponential increase in knowledge about the genetic basis of complex human traits, including neuropsychiatric disorders. It is not clear, however, to what extent this knowledge can be used as a starting point for drug identification, one of the central hopes of the human genome project. The aim of the present study was to identify memory-modulating compounds through the use of human genetic information. We performed a multinational collaborative study, which included assessment of aversive memory-a trait central to posttraumatic stress disorder-and a gene-set analysis in healthy individuals. We identified 20 potential drug target genes in two genomewide-corrected gene sets: the neuroactive ligand-receptor interaction and the long-term depression gene set. In a subsequent double-blind, placebo-controlled study in healthy volunteers, we aimed at providing a proof of concept for the genome-guided identification of memory modulating compounds. Pharmacological intervention at the neuroactive ligand-receptor interaction gene set led to significant reduction of aversive memory. The findings demonstrate that genome information, along with appropriate data mining methodology, can be used as a starting point for the identification of memory-modulating compounds.
Publishing Year
ISSN
eISSN
PUB-ID

Cite this

Papassotiropoulos A, Gerhards C, Heck A, et al. Human genome-guided identification of memory-modulating drugs. Proceedings of the National Academy of Sciences of the United States of America. 2013;110(46):E4369-E4374.
Papassotiropoulos, A., Gerhards, C., Heck, A., Ackermann, S., Aerni, A., Schicktanz, N., Auschra, B., et al. (2013). Human genome-guided identification of memory-modulating drugs. Proceedings of the National Academy of Sciences of the United States of America, 110(46), E4369-E4374.
Papassotiropoulos, A., Gerhards, C., Heck, A., Ackermann, S., Aerni, A., Schicktanz, N., Auschra, B., Demougin, P., Mumme, E., Elbert, T., et al. (2013). Human genome-guided identification of memory-modulating drugs. Proceedings of the National Academy of Sciences of the United States of America 110, E4369-E4374.
Papassotiropoulos, A., et al., 2013. Human genome-guided identification of memory-modulating drugs. Proceedings of the National Academy of Sciences of the United States of America, 110(46), p E4369-E4374.
A. Papassotiropoulos, et al., “Human genome-guided identification of memory-modulating drugs”, Proceedings of the National Academy of Sciences of the United States of America, vol. 110, 2013, pp. E4369-E4374.
Papassotiropoulos, A., Gerhards, C., Heck, A., Ackermann, S., Aerni, A., Schicktanz, N., Auschra, B., Demougin, P., Mumme, E., Elbert, T., Ertl, V., Gschwind, L., Hanser, E., Huynh, K.-D., Jessen, F., Kolassa, I.-T., Milnik, A., Paganetti, P., Spalek, K., Vogler, C., Muhs, A., Pfeifer, A., de Quervain, D.J.-F.: Human genome-guided identification of memory-modulating drugs. Proceedings of the National Academy of Sciences of the United States of America. 110, E4369-E4374 (2013).
Papassotiropoulos, Andreas, Gerhards, Christiane, Heck, Angela, Ackermann, Sandra, Aerni, Amanda, Schicktanz, Nathalie, Auschra, Bianca, Demougin, Philippe, Mumme, Eva, Elbert, Thomas, Ertl, Verena, Gschwind, Leo, Hanser, Edveena, Huynh, Kim-Dung, Jessen, Frank, Kolassa, Iris-Tatjana, Milnik, Annette, Paganetti, Paolo, Spalek, Klara, Vogler, Christian, Muhs, Andreas, Pfeifer, Andrea, and de Quervain, Dominique J-F. “Human genome-guided identification of memory-modulating drugs”. Proceedings of the National Academy of Sciences of the United States of America 110.46 (2013): E4369-E4374.
This data publication is cited in the following publications:
This publication cites the following data publications:

4 Citations in Europe PMC

Data provided by Europe PubMed Central.

Computational dissection of human episodic memory reveals mental process-specific genetic profiles.
Luksys G, Fastenrath M, Coynel D, Freytag V, Gschwind L, Heck A, Jessen F, Maier W, Milnik A, Riedel-Heller SG, Scherer M, Spalek K, Vogler C, Wagner M, Wolfsgruber S, Papassotiropoulos A, de Quervain DJ., Proc. Natl. Acad. Sci. U.S.A. 112(35), 2015
PMID: 26261317
Systems Genetics Analysis of Genome-Wide Association Study Reveals Novel Associations Between Key Biological Processes and Coronary Artery Disease.
Ghosh S, Vivar J, Nelson CP, Willenborg C, Segre AV, Makinen VP, Nikpay M, Erdmann J, Blankenberg S, O'Donnell C, Marz W, Laaksonen R, Stewart AF, Epstein SE, Shah SH, Granger CB, Hazen SL, Kathiresan S, Reilly MP, Yang X, Quertermous T, Samani NJ, Schunkert H, Assimes TL, McPherson R., Arterioscler. Thromb. Vasc. Biol. 35(7), 2015
PMID: 25977570
Failed drug discovery in psychiatry: time for human genome-guided solutions.
Papassotiropoulos A, de Quervain DJ., Trends Cogn. Sci. (Regul. Ed.) 19(4), 2015
PMID: 25727774
FASTKD2 is associated with memory and hippocampal structure in older adults.
Ramanan VK, Nho K, Shen L, Risacher SL, Kim S, McDonald BC, Farlow MR, Foroud TM, Gao S, Soininen H, Kloszewska I, Mecocci P, Tsolaki M, Vellas B, Lovestone S, Aisen PS, Petersen RC, Jack CR Jr, Shaw LM, Trojanowski JQ, Weiner MW, Green RC, Toga AW, De Jager PL, Yu L, Bennett DA, Saykin AJ., Mol. Psychiatry 20(10), 2015
PMID: 25385369

38 References

Data provided by Europe PubMed Central.

Acute and subchronic effects of levocetirizine and diphenhydramine on memory functioning, psychomotor performance, and mood.
Verster JC, Volkerts ER, van Oosterwijck AW, Aarab M, Bijtjes SI, De Weert AM, Eijken EJ, Verbaten MN., J. Allergy Clin. Immunol. 111(3), 2003
PMID: 12642847
Initial and steady-state effects of diphenhydramine and loratadine on sedation, cognition, mood, and psychomotor performance.
Kay GG, Berman B, Mockoviak SH, Morris CE, Reeves D, Starbuck V, Sukenik E, Harris AG., Arch. Intern. Med. 157(20), 1997
PMID: 9361576
Sedation and memory: studies with a histamine H-1 receptor antagonist.
Turner C, Handford AD, Nicholson AN., J. Psychopharmacol. (Oxford) 20(4), 2006
PMID: 16401664
Neutral and emotional episodic memory: global impairment after lorazepam or scopolamine.
Kamboj SK, Curran HV., Psychopharmacology (Berl.) 188(4), 2006
PMID: 17047934
Effects of melatonin on human mood and performance.
Lieberman HR, Waldhauser F, Garfield G, Lynch HJ, Wurtman RJ., Brain Res. 323(2), 1984
PMID: 6525511
Morphine use after combat injury in Iraq and post-traumatic stress disorder.
Holbrook TL, Galarneau MR, Dye JL, Quinn K, Dougherty AL., N. Engl. J. Med. 362(2), 2010
PMID: 20071700
Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci.
Stahl EA, Raychaudhuri S, Remmers EF, Xie G, Eyre S, Thomson BP, Li Y, Kurreeman FA, Zhernakova A, Hinks A, Guiducci C, Chen R, Alfredsson L, Amos CI, Ardlie KG; BIRAC Consortium, Barton A, Bowes J, Brouwer E, Burtt NP, Catanese JJ, Coblyn J, Coenen MJ, Costenbader KH, Criswell LA, Crusius JB, Cui J, de Bakker PI, De Jager PL, Ding B, Emery P, Flynn E, Harrison P, Hocking LJ, Huizinga TW, Kastner DL, Ke X, Lee AT, Liu X, Martin P, Morgan AW, Padyukov L, Posthumus MD, Radstake TR, Reid DM, Seielstad M, Seldin MF, Shadick NA, Steer S, Tak PP, Thomson W, van der Helm-van Mil AH, van der Horst-Bruinsma IE, van der Schoot CE, van Riel PL, Weinblatt ME, Wilson AG, Wolbink GJ, Wordsworth BP; YEAR Consortium, Wijmenga C, Karlson EW, Toes RE, de Vries N, Begovich AB, Worthington J, Siminovitch KA, Gregersen PK, Klareskog L, Plenge RM., Nat. Genet. 42(6), 2010
PMID: 20453842

Export

0 Marked Publications

Open Data PUB

Web of Science

View record in Web of Science®

Sources

PMID: 24145423
PubMed | Europe PMC

Search this title in

Google Scholar